Kaleido Biosciences Inc (KLDO) is around the middle of the Biotechnology industry according to InvestorsObserver. KLDO received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Kaleido Biosciences Inc also achieved a score of 48 in the Biotechnology industry, putting it above 48 percent of Biotechnology stocks. Biotechnology is ranked 85 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 40 means the stock is more attractive than 40 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Kaleido Biosciences Inc Stock Today?
Kaleido Biosciences Inc (KLDO) stock is lower by -5.03% while the S&P 500 is higher by 0.52% as of 11:08 AM on Friday, Mar 26. KLDO is down -$0.42 from the previous closing price of $8.35 on volume of 119,226 shares. Over the past year the S&P 500 is higher by 49.42% while KLDO is higher by 32.17%. KLDO lost -$2.44 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Kaleido Biosciences Inc (KLDO) Stock.
